ICON

Yahoo Finance • 17 days ago

Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc

This article first appeared on GuruFocus. Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2025, shedding light on its strategic... Full story

Yahoo Finance • 19 days ago

Here’s Why ICON Plc. (ICLR) Gained +20.3% in Q3

GreensKeeper Asset Management, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Value Fund has ended the quarter with a +4.0% gain, taking the YTD return to... Full story

Yahoo Finance • 26 days ago

BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call

ICON Public Limited Company (NASDAQ:ICLR) is among the cheap healthcare stocks to buy heading into 2026. On December 4, BMO Capital maintained its ‘Market Perform’ rating and $175 price target on ICON Public Limited Company (NASDAQ:ICLR) a... Full story

Yahoo Finance • 2 months ago

Seth Klarman's Baupost takes stake in Union Pacific, exits ViaSat, among Q3 trades

[Allen & Co. Holds Its Annual Sun Valley Conference In Idaho] Drew Angerer Baupost acquired new stakes in Union Pacific (UNP [https://seekingalpha.com/symbol/UNP]), boosted holdings in Restaurant Brands (QSR [https://seekingalpha.com/symb... Full story

Yahoo Finance • 2 months ago

ICON Public Limited Company (ICLR) Soared on Robust Performance

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabiliz... Full story

Yahoo Finance • 4 months ago

Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy

ICON Public Limited Company (NASDAQ:ICLR) is one of the best cheap stocks to buy for beginners. On September 9, Jefferies analyst David Windley downgraded ICON Public Limited Company (NASDAQ:ICLR) to Hold from Buy, bringing the price targe... Full story

Yahoo Finance • 4 months ago

IQVIA Holdings Inc. (IQV): A Bull Case Theory

We came across a bullish thesis on IQVIA Holdings Inc. on Rebound Capital’s Substack. In this article, we will summarize the bulls’ thesis on IQV. IQVIA Holdings Inc.'s share was trading at $191.15 as of August 22nd. IQV’s trailing and for... Full story

Yahoo Finance • 4 months ago

Can AI make clinical trials better?

Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story

Yahoo Finance • 5 months ago

Earnings call transcript: ICON plc beats Q2 2025 earnings expectations

ICON plc reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) of $3.26, surpassing the forecast of $3.19. This positive surprise, combined with revenue exceeding projections, led to a signifi... Full story

Yahoo Finance • 5 months ago

ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals

ICON PLC (NASDAQ:ICLR [https://www.chartmill.com/stock/quote/ICLR]) has been recognized using a "Decent Value" screening method, focusing on stocks with favorable valuation metrics alongside steady fundamentals in growth, profitability, an... Full story

Yahoo Finance • 5 months ago

ICON suspends COVID vaccine study after BARDA notice

[A woman using Covid-19 rapid self-test kit at home] Images By Tang Ming Tung ICON plc (NASDAQ:ICLR [https://seekingalpha.com/symbol/ICLR]) has announced the suspension of its COVID vaccine study following a stop work notice from BARDA.... Full story

Yahoo Finance • 5 months ago

Steven Romick's Strategic Moves: A Closer Look at Amrize Ltd's Impactful Addition

Exploring the Latest N-PORT Filing and Portfolio Adjustments Steven Romick (Trades, Portfolio) recently submitted the N-PORT filing for the second quarter of 2025, providing insights into his investment moves during this period. Steven Ro... Full story

Yahoo Finance • 5 months ago

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Earnings Call Insights: ICON Public Limited Company (ICLR) Q2 2025 MANAGEMENT VIEW * CEO Steven A. Cutler highlighted an 11% sequential increase in gross business awards over quarter 1, driven by wins from biotech customers and ongoing... Full story

Yahoo Finance • 5 months ago

Evercore ISI raises ICON stock price target to $240 on improving demand

Investing.com - Evercore ISI has raised its price target on ICON plc (NASDAQ:ICLR) to $240.00 from $170.00 while maintaining an Outperform rating on the clinical research organization. The new target approaches the high end of analyst esti... Full story

Yahoo Finance • 5 months ago

Icon Non-GAAP EPS of $3.26 beats by $0.08, revenue of $2.01B beats by $30M

* Icon press release [https://seekingalpha.com/pr/20175881-icon-reports-second-quarter-2025-results] (NASDAQ:ICLR [https://seekingalpha.com/symbol/ICLR]): Q2 Non-GAAP EPS of $3.26 beats by $0.08. * Revenue of $2.01B (-5.2% Y/Y) beats b... Full story

Yahoo Finance • 5 months ago

Iqvia, Medpace send CRO peers higher after Q2 beats

[Quarterly results] CharlieAJA/iStock via Getty Images Shares of contract research organizations climbed in the premarket on Tuesday after two industry leaders, IQVIA Holdings (NYSE:IQV [https://seekingalpha.com/symbol/IQV]) and Medpace H... Full story

Yahoo Finance • 6 months ago

Do You Believe in the Upside Potential of ICON PLC (ICLR)?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% f... Full story

Yahoo Finance • 6 months ago

Validea Detailed Fundamental Analysis - ICLR

Below is Validea's guru fundamental report for ICON PLC (ICLR). Of the 22 guru strategies we follow, ICLR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story

Yahoo Finance • 6 months ago

ICON plc stock price target lowered to $187 at Truist Securities

Investing.com - Truist Securities has lowered its price target on ICON plc (NASDAQ:ICLR) to $187.00 from $190.00 while maintaining a Buy rating on the stock. Currently trading at $152.45, InvestingPro analysis suggests the stock is underva... Full story

Yahoo Finance • 6 months ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

DUBLIN, July 07, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the comp... Full story